Zhiyuan Hu

4PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Circuits and systemsImmunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.

Jonathan H Shepherd, Karla Ballman, Mei-Yin C Polley

|Nov 06, 2018
An assessment of prognostic immunity markers in breast cancer.

Benlong Yang, Jeff Chou, Yaozhong Tao

|Jul 25, 2018
Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.

Maki Tanioka, Cheng Fan, Joel S Parker

Pageof 1